Evidence map›Paper›PMID 35956985›Full record

ArticleMolecules (Basel, Switzerland)2022

Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3

Fengmao An, Xinran Xuan, Zheng Liu, Ming Bian, Qingkun Shen, Zheshan Quan, Guowei Zhang, Chengxi Wei

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fengmao AnInstitute of Pharmaceutical Chemistry and Pharmacology, Inner Mongolia Minzu University, Tongliao 028000, China.
Xinran XuanFirst Clinical Medical College, Inner Mongolia Minzu University, Tongliao 028000, China.
Zheng LiuCollege of Pharmacy, Yanbian University, Yanji 133002, China.
Ming BianInstitute of Pharmaceutical Chemistry and Pharmacology, Inner Mongolia Minzu University, Tongliao 028000, China.
Qingkun ShenCollege of Pharmacy, Yanbian University, Yanji 133002, China.
Zheshan QuanCollege of Pharmacy, Yanbian University, Yanji 133002, China.
Guowei ZhangCollege of Nursing, Inner Mongolia Minzu University, Tongliao 028000, China.
Chengxi WeiInstitute of Pharmaceutical Chemistry and Pharmacology, Inner Mongolia Minzu University, Tongliao 028000, China.
Minzu University of China · CNYanbian University · CN

Funding

Central Government Funds for Guiding Local Scientific and Technological Development of Inner Mongolia Autonomous Region 2021ZY0014National Natural Science Foundation of China 82160823, 82160958, 81660720, 81660675PhD Science Research Initiation Foundation of Inner Mongolia Minzu University BS406Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region NJYT-20-B24The Natural Science Foundation of Inner Mongolia 2018JQ01
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a major neurodegenerative disease, but so far, it can only be treated symptomatically rather than changing the process of the disease. Recently, triazoles and their derivatives have been shown to have potential for the treatment of AD. In this study, the neuroprotective effects of 4-(4-(heptyloxy)phenyl)-2,4-dihydro-3

Indexed as

Alzheimer DiseaseNeurodegenerative DiseasesNeuroprotective AgentsAmyloid beta-PeptidesAnimalsAnti-Inflammatory AgentsMAP Kinase Signaling SystemNF-kappa BRatsAmyloid beta-PeptidesAnti-Inflammatory AgentsNeuroprotective AgentsNF-kappa BAlzheimer’s diseaseamyloid beta-peptidesmitogen-activated protein kinase/NF-kappa B signaling pathwaysneuroinflammationtriazoles

Identifiers

PMID35956985
PMCPMC9370156
OpenAlexW4292452193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.